Literature DB >> 3950226

Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease.

M L Ladenheim, B H Pollock, A Rozanski, D S Berman, H M Staniloff, J S Forrester, G A Diamond.   

Abstract

The ability of exercise-induced myocardial hypoperfusion on thallium scintigraphy to predict coronary events was assessed in 1,689 patients with symptoms suggestive of coronary artery disease but without prior myocardial infarction or coronary artery bypass surgery. A total of 74 patients had a coronary event in the year after testing (12 cardiac deaths, 20 nonfatal infarctions and 42 referrals for bypass surgery more than 60 days after testing). Stepwise logistic regression identified only three independent predictors: the number of myocardial regions with reversible hypoperfusion (an index of the extent of hypoperfusion), the maximal magnitude of hypoperfusion (an index of the severity of hypoperfusion) and the achieved heart rate (an index of exercise performance). Both extent and severity were exponentially correlated with event rate (r greater than 0.97 and p less than 0.01 for each), whereas achieved heart rate was linearly correlated with event rate (r = 0.79 and p less than 0.05). On the basis of these data, a prognostic model was defined that employs extent and severity as stress-dependent orthogonal variables. Using this model, the predicted coronary event rate ranged over two orders of magnitude--from a low of 0.4% in patients able to exercise adequately without developing severe and extensive hypoperfusion at a low heart rate (less than 85% of their maximal predicted heart rate). Extent and severity of myocardial hypoperfusion, therefore, are important independent variables of prognosis in patients with suspected coronary artery disease.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3950226     DOI: 10.1016/s0735-1097(86)80454-5

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  77 in total

1.  The challenge of quantifying defect size and severity: reality versus algorithm.

Authors:  R L Eisner; R E Patterson
Journal:  J Nucl Cardiol       Date:  1999 May-Jun       Impact factor: 5.952

Review 2.  Nuclear cardiology approaches to defining normal and abnormal cardiovascular aging.

Authors:  J L Fleg; S P Schulman
Journal:  J Nucl Cardiol       Date:  1999 Sep-Oct       Impact factor: 5.952

Review 3.  An overview of radiotracers in nuclear cardiology.

Authors:  W Acampa; C Di Benedetto; A Cuocolo
Journal:  J Nucl Cardiol       Date:  2000 Nov-Dec       Impact factor: 5.952

4.  Proceedings of the 4th Invitational Wintergreen Conference. Wintergreen, Virginia, USA. July 12-14, 1998. Abstracts.

Authors: 
Journal:  J Nucl Cardiol       Date:  1999 Jan-Feb       Impact factor: 5.952

5.  Investigation and management of stable angina: revised guidelines 1998. Joint Working Party of the British Cardiac Society and Royal College of Physicians of London.

Authors:  D de Bono
Journal:  Heart       Date:  1999-05       Impact factor: 5.994

Review 6.  Comparison of Tl-201 with Tc-99m-labeled myocardial perfusion agents: technical, physiologic, and clinical issues.

Authors:  P Kailasnath; A J Sinusas
Journal:  J Nucl Cardiol       Date:  2001 Jul-Aug       Impact factor: 5.952

Review 7.  Pharmacologic stress testing: new methods and new agents.

Authors:  Robert C Hendel; Tariq Jamil; David K Glover
Journal:  J Nucl Cardiol       Date:  2003 Mar-Apr       Impact factor: 5.952

8.  Gating of myocardial perfusion imaging for the identification of artifacts: is it useful for experienced physicians?

Authors:  S N Chatziioannou; W H Moore; R D Dhekne; P V Ford
Journal:  Tex Heart Inst J       Date:  2000

Review 9.  Assessing clinical impact of myocardial perfusion studies: ischemia or other prognostic indicators?

Authors:  Todd D Miller; John Wells Askew; Joerg Herrmann
Journal:  Curr Cardiol Rep       Date:  2014-04       Impact factor: 2.931

Review 10.  Myocardial ischemia is a key factor in the management of stable coronary artery disease.

Authors:  Kohichiro Iwasaki
Journal:  World J Cardiol       Date:  2014-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.